At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 enrolled
Drug / intervention
Dexmedetomidine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of Single Dose Dexmedetomidine or Dexmedetomidine Combined With Dexamethasone on Postoperative Nausea and Vomiting in Breast Cancer
In Brief
A clinical study evaluating Dexmedetomidine, Dexmedetomidine and dexamethasone, and 1 other intervention for Postoperative Nausea and Vomiting. Completed, enrolled 150 participants.
Detailed Summary
Previous reports demonstrated that dexmedetomidine could reduce the incidence of postoperative nausea and vomiting (PONV). Dexamethason also had been commonly used for ajuvant drugs for preventing and reducing PONV. So investigator want to study about the effect of dexmedetomidine only or combined with dexamethasone for preventing PONV.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPostoperative Nausea and Vomiting
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
First PostedSep 2015
Primary CompletionAug 2016
Study CompletionDec 2016
TodayJul 2026
First PostedSep 16, 2015
Enrollment StartSep 1, 2015
Primary CompletionAug 1, 2016
Study CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.8 years ago
Interventions
Dexmedetomidinedrug
administration of dexmedetomidine only
Dexmedetomidine and dexamethasonedrug
administration of dexmedetomidine and dexamethasone
Controldrug
administration of normal saline